Publications by authors named "Paul Hamlin"

69Publications

Treatment of Rosai-Dorfman disease with oral bexarotene: a case series.

J Dermatolog Treat 2019 Aug 19;30(5):503-505. Epub 2018 Nov 19.

a Dermatology Service, Department of Medicine , Memorial Sloan Kettering Cancer Center, and Weill Cornell Medicine , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/09546634.2018.1528001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526080PMC
August 2019

Multicenter Phase II Study of Sequential Brentuximab Vedotin and Doxorubicin, Vinblastine, and Dacarbazine Chemotherapy for Older Patients With Untreated Classical Hodgkin Lymphoma.

J Clin Oncol 2018 10 4;36(30):3015-3022. Epub 2018 Sep 4.

Andrew M. Evens, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Ranjana H. Advani, Stanford University, Stanford, CA; Irene B. Helenowski, Borko D. Jovanovic, Jane N. Winter, and Leo I. Gordon, Northwestern University Feinberg School of Medicine; Jane N. Winter and Leo I. Gordon, Robert H. Lurie Comprehensive Cancer Center; Sonali M. Smith, University of Chicago, Chicago, IL; Michelle Fanale, University of Texas MD Anderson Cancer Center, Houston, TX; Gregory R. Bociek, University of Nebraska, Omaha, NE; Andreas K. Klein, Tufts Medical Center, Boston, MA; and Paul A. Hamlin, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.79.0139DOI Listing
October 2018

Development of a Geriatric Service in a Cancer Center: Lessons Learned.

J Oncol Pract 2017 02;13(2):107-112

Memorial Sloan Kettering Cancer Center, New York, NY; and City of Hope Comprehensive Cancer Center, Duarte, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.017590DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455157PMC
February 2017

Nuances in the Management of Aggressive Lymphomas.

J Adv Pract Oncol 2017 Apr 1;8(3):279-284. Epub 2017 Apr 1.

Memorial Sloan Kettering Cancer Center, New York New York.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003762PMC
April 2017

Obinutuzumab plus bendamustine in rituximab-refractory indolent lymphoma.

Authors:
Paul A Hamlin

Lancet Oncol 2016 08 23;17(8):1023-1025. Epub 2016 Jun 23.

Basking Ridge Medical Oncology Service; and Lymphoma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Medical College, New York Presbyterian Hospital, Department of Medicine, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)30157-7DOI Listing
August 2016

Central nervous system involvement in T-cell lymphoma: A single center experience.

Acta Oncol 2016 May 4;55(5):561-6. Epub 2016 Apr 4.

c Lymphoma Service, Department of Medicine , Memorial Sloan Kettering Cancer Center , New York , New York , USA ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2015.1118656DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376067PMC
May 2016

A Positive Prospective Trial of Antibiotic Therapy in Advanced Stage, Non-Bulky Indolent Lymphoma.

Tumor Microenviron Ther 2015 Feb 18;2(1):14-18. Epub 2015 Feb 18.

Memorial Sloan Kettering Cancer Center, Department of Medicine, 1275 York Avenue New York, NY, 10065 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/tumor-2015-0001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718606PMC
February 2015

High-Dose Chemotherapy and Autologous Stem Cell Transplant in Older Patients with Lymphoma.

Curr Oncol Rep 2015 Sep;17(9):42

Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-015-0465-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542393PMC
September 2015

Treatment patterns and comparative effectiveness in elderly diffuse large B-cell lymphoma patients: a surveillance, epidemiology, and end results-medicare analysis.

Oncologist 2014 Dec 23;19(12):1249-57. Epub 2014 Oct 23.

Memorial Sloan-Kettering Cancer Center, New York, New York, USA; Q.D. Research, Inc., Granite Bay, California, USA; Genentech, Inc., South San Francisco, California, USA; University of California San Francisco, San Francisco, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257739PMC
December 2014

Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma.

Biol Blood Marrow Transplant 2014 Dec 28;20(12):2004-9. Epub 2014 Aug 28.

Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791140053
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2014.08.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480286PMC
December 2014

Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma.

Invest New Drugs 2014 Dec 22;32(6):1246-57. Epub 2014 Aug 22.

MD, FACP; MD Anderson Cancer Center, Department of Genitourinary Medical Oncology, 1155 Pressler St, Unit 1374, Houston, TX, 77030, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-014-0151-0DOI Listing
December 2014

Personalizing therapy for older adults with lymphoid malignancies: options and obstacles.

Am Soc Clin Oncol Educ Book 2014 :e240-8

From the Washington University School of Medicine, St. Louis, MO; University Hospital, Cologne, Germany; Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2014.34.e240DOI Listing
November 2015

Evolving treatment paradigms for primary mediastinal diffuse large B-cell lymphoma.

Authors:
Paul A Hamlin

J Clin Oncol 2014 Jun 5;32(17):1751-3. Epub 2014 May 5.

Memorial Sloan Kettering Cancer Center; Weill Cornell Medical College, New York, NY

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.2810DOI Listing
June 2014

A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remission.

Clin Lymphoma Myeloma Leuk 2013 Dec 11;13(6):664-70. Epub 2013 Sep 11.

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2013.07.005DOI Listing
December 2013

Testis-isolated mantle cell lymphoma: a unique case.

Clin Lymphoma Myeloma Leuk 2011 Oct 8;11(5):439-41. Epub 2011 Sep 8.

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2011.06.013DOI Listing
October 2011

Is maintenance rituximab now ready for PRIMA-time?

Authors:
Paul A Hamlin

Curr Oncol Rep 2010 Nov;12(6):355-7

Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-010-0124-1DOI Listing
November 2010

Meta-analysis: making sense of maintenance rituximab?

Authors:
Paul A Hamlin

Curr Oncol Rep 2009 Sep;11(5):329-30

Memorial Sloan-Kettering Cancer Center Lymphoma Service, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-009-0055-xDOI Listing
September 2009

Distress in older patients with cancer.

J Clin Oncol 2009 Sep 3;27(26):4346-51. Epub 2009 Aug 3.

Cancer and Aging Research Program, City of Hope, 1500 E Duarte Rd, Duarte, CA 91001, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.19.9463DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2799049PMC
September 2009

Do six or eight cycles work better with CHOP-14 and rituximab?

Authors:
Paul A Hamlin

Curr Oncol Rep 2008 Sep;10(5):391-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-008-0060-5DOI Listing
September 2008

A multicentre phase II clinical experience with the novel aza-epothilone Ixabepilone (BMS247550) in patients with relapsed or refractory indolent non-Hodgkin lymphoma and mantle cell lymphoma.

Br J Haematol 2008 Oct 4;143(2):201-9. Epub 2008 Aug 4.

Department of Medicine, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, Lymphoma Service, New York, NY 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2008.07271.xDOI Listing
October 2008

Identifying vulnerable older adults with cancer: integrating geriatric assessment into oncology practice.

J Am Geriatr Soc 2007 Oct 14;55(10):1604-8. Epub 2007 Aug 14.

Division of Medical Oncology and Therapeutics Research, City of Hope, Duarte, California 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1532-5415.2007.01367.xDOI Listing
October 2007

New drugs for the treatment of advanced-stage diffuse large cell lymphomas.

Semin Hematol 2006 Oct;43(4):251-61

Laboratory of Experimental Therapeutics for the Lymphoproliferative Malignancies, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2006.07.002DOI Listing
October 2006

Idiopathic cholestasis as a paraneoplastic phenomenon in Hodgkin's lymphoma.

Clin Lymphoma Myeloma 2006 Jul;7(1):77-82

Department of Medicine, St. Luke's Roosevelt Hospital Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLM.2006.n.044DOI Listing
July 2006

Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma.

Br J Haematol 2006 Jul 6;134(2):202-7. Epub 2006 Jun 6.

Hematology Services, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2006.06164.xDOI Listing
July 2006

Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed and refractory DLBCL.

Blood 2005 Nov 9;106(10):3383-5. Epub 2005 Aug 9.

Lymphoma and Hematology Services of the Division of Hematological Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-04-1603DOI Listing
November 2005

Primary lymphoma of the breast: a case of marginal zone B-cell lymphoma.

Am Surg 2004 Aug;70(8):720-5

Breast Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
August 2004

New strategies in radioimmunotherapy for lymphoma.

Curr Oncol Rep 2003 Sep;5(5):364-71

Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-003-0020-zDOI Listing
September 2003

Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma.

Blood 2003 Sep 3;102(6):1989-96. Epub 2003 Apr 3.

Lymphoma and Hematology Services, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Box 350, 1275 York Ave, New York, NY, 10021.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2002-12-3837DOI Listing
September 2003